Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis

By sjmartinez • April 6, 2023

Ballav S, Bhosale M, Lokhande KB, Paul MK, Padhye S, Swamy KV, Ranjan A, Basu S. Design, Synthesis, and Biological Evaluation of Novel Quercetin Derivatives as PPAR-γ Partial Agonists by Modulating Epithelial-Mesenchymal Transition in Lung Cancer Metastasis. Adv Biol (Weinh). 2023 Apr 5:e2300036. doi: 10.1002/adbi.202300036. Epub ahead of print. PMID: 37017501.

Tags: EMT, Lung cancer, Partial agonist, PPAR-γ, Publications, Pulmonary, Critical Care & Sleep Medicine, Quercetin derivatives, Schiff base

Trends in Dermato-polymyositis Mortality, 1999-2022: A Nationwide Population-based Study, United States

Matz E, Singh RR. Trends in Dermato-polymyositis Mortality, 1999-2022: A Nationwide Population-based Study, United States. Arthritis Care Res (Hoboken). 2025 Jul 14. doi: 10.1002/acr.25609. Epub[...]

Refractive Index-Corrected Light-Sheet Microscopy for Macro-View Cardiovascular Imaging

Zhu E, Zhang Y, Zhao P, Cho JM, Wang Z, Li YR, Wang J, Margolis S, Wang S, Yang L, Chu A, Zhang Y, Gao[...]

Modulation of the PTPRS proteoglycan switch by antibodies binding to the membrane-proximal fibronectin-type III domain

Hein Da Rosa T, Ramsey SH, Lee JJ, Kozlova NY, Zhao Z, Kim J, Schneider AC, Li S, Katiki M, Firestein GS, Murali R, Santelli[...]